Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's Disease: An Observational, Retrospective cohort Study

Inflammatory Bowel Diseases

Volumn 16, Issue 7, 2010, Pages 1219-1226

  Parisinos, C A ^a   McIntyre, V E D ^a   Heron, T ^b   Subedi, D ^c   Arnott, I D R ^a   Mowat, C ^b   Wilson, D C ^d   McGurk, S ^d   Glancy, S ^d   Zealley, I A ^b   Satsangi, J ^a   Lees, C W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Crohn's; Inflammation; MRI; Small bowel

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN; CORTICOSTEROID; ENEMA; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; ILEUM; INFLAMMATION; INTESTINAL FIBROSIS; INTESTINE FISTULA; KIDNEY CANCER; MAGNETIC RESONANCE FOLLOW THROUGH; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE; RELIABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SENSIBILITY;

ADULT; C-REACTIVE PROTEIN; COHORT STUDIES; COLONOSCOPY; CROHN DISEASE; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ILEAL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 77953694417     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21168     Document Type: Article

References (29)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1657.
2. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782.
3. Van LJ, Russell RK, Drummond HE, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008;135:1114-1122.
4. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
5. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis. 2002;8:244-250. (Pubitemid 34784976)
6. Patak MA, Mortele KJ, Ros PR. Multidetector row CT of the small bowel. Radiol Clin North Am. 2005;43:1063-1077, viii.
7. Koh DM, Miao Y, Chinn RJ, et al. MR imaging evaluation of the activity of Crohn's disease. AJR Am J Roentgenol. 2001;177:1325-1332. (Pubitemid 33081474)
8. Laghi A, Borrelli O, Paolantonio P, et al. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. Gut. 2003;52:393-397.
9. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000;25:219-228.
10. Chiorean MV, Sandrasegaran K, Saxena R, et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol. 2007;102:2541-2550.
11. Desmond AN, O'Regan K, Curran C, et al. Crohn's disease: factors associated with exposure to high levels of diagnostic radiation. Gut. 2008;57:1524-1529.
12. Martin DR, Semelka RC. Health effects of ionising radiation from diagnostic CT. Lancet. 2006;367:1712-1714.
13. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A): 5-36.
14. Lauenstein TC, Schneemann H, Vogt FM, et al. Optimization of oral contrast agents for MR imaging of the small bowel. Radiology. 2003;228:279-283.
15. Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol. 2007;17:2294-2301.
16. Zhu J, Xu JR, Gong HX, et al. Updating magnetic resonance imaging of small bowel: imaging protocols and clinical indications. World J Gastroenterol. 2008;14:3403-3409.
17. Dinter DJ, Chakraborty A, Brade J, et al. Endoscopy and magnetic resonance imaging in patients with Crohn's disease: a retrospective single-centre comparative study. Scand J Gastroenterol. 2008;43:207-216.
18. Rimola J, Rodriguez S, Garcia BO, et al. Magnetic resonance for assessment of disease activity and severity in Crohn disease. Gut. 2009;588:113-120.
19. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology. 2009;252:712-720.
20. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology. 2006;238:517-530.
21. von Roon AC, Karamountzos L, Purkayastha S, et al. Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy. Am J Gastroenterol. 2007;102:803-813.
22. Gourtsoyiannis NC, Papanikolaou N, Karantanas A. Magnetic resonance imaging evaluation of small intestinal Crohn's disease. Best Pract Res Clin Gastroenterol. 2006;20:137-156.
23. Bernstein CN, Greenberg H, Boult I, et al. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease. Am J Gastroenterol. 2005;100:2493-2502.
24. Rieber A, Aschoff A, Nussle K, et al. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol. 2000;10:1377-1382.
25. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution. Invest Radiol. 2000;35:707-711.
26. Schreyer AG, Geissler A, Albrich H, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol. 2004;2:491-497.
27. Bodily KD, Fletcher JG, Solem CA, et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography - correlation with endoscopic and histologic findings of inflammation. Radiology. 2006;238:505-516.
28. Colombel JF, Solem CA, Sandborn WJ, et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut. 2006;55:1561-1567.
29. Wold PB, Fletcher JG, Johnson CD, et al. Assessment of small bowel Crohn's disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy - feasibility study. Radiology. 2003;229:275-281.